Search

Issue
Title
Authors
Analysis of the survival rate of patients with ovarian cancer of stages I–IV: A retrospective study
Zhurman V.N.
Therapy results of advanced-stag Hodgkin lymphoma in Khabarovsk district
Kanin V.S., Kanin E.S., Dolgaleva M.I.
Results of pelvic exenteration in patients with cervical cancer: clinical experience
Khakimov G.A., Khakimova G.G.
Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer
Popova A.S., Fedyanin M.Y., Pokataev I.A., Tyulyandin S.A.
What are the harms and benefits of using pegylated liposomal doxorubicin in women with recurrent epithelial ovarian cancer, alone or in combination with other drugs? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Editorial B.
Efficacy of immunotherapy (Prolgolimab) and targeted therapy (Trametinib and Dabrafenib, Cobimetinib and Vemurafenib) in adult patients with metastatic or unresectable skin melanoma: matching-adjusted indirect comparison
Sapozhnikov K.V., Sokolova V.D., Sableva N.A., Tolkacheva D.G.
Targeted therapy for metastatic renal cell carcinoma
Porta C., Tsimafeyev I.V.
Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data
Savchenko I.V., Stilidi I.S., Dzhanyan I.A., Antonova E.Y., Polyakov A.N., Egorova A.V., Chulkova S.V., Breder V.V.
Effective prevention of COVID-19 infection in cancer patients receiving antitumor drug therapy: a regional analysis
Valiachmetova C.K., Siraev E.R., Izmailov A.A.
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary)
Staroverova T.A.
Systemic treatments for metastatic cutaneous melanoma (Russian Translation of Cochrane Plain Language Summary – PLS)
Ziganshin A.U.
Clinico-morphological predictors and treatment outcomes in cervical stump cancer
Usmanova L.S., Kuznetsov V.V., Mustafina E.A., Barinov V.V., Bokin I.I., Knyazev R.I., Akhmedova M.D.
The role of minimal residual disease in therapy of pediatric acute lymphoblastic leukemia: a prospective cohort study
Korkina Y.S., Valiev T.T.
Quality of life and overall survival are primary priorities of patients with advanced breast cancer: results of sociological research
Kolomejtseva A.A., Bokova S.E.
Second-line systemic therapy for metastatic colorectal cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Zaleeva A.R.
Which chemotherapy treatments are best for helping people with advanced pancreatic cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Kinaly I.
Comparative analysis results of surgical treatment, chemoradiotherapy and chemotherapy with assessment of prognostic factors in cervical esophageal cancer
Radzhabova Z.A., Kotov M.A., Girshovich M.M., Ponomareva O.I., Tkachenko E.V., Mitrofanov A.S., Radzhabova M.A., Levchenko E.V.
Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
Karabina E.V., Zhukova L.G.
Effect of transfused donor and autoerythrocytes on the oncological outcomes of surgical treatment in patients with renal cell carcinoma with tumor-related venous thrombosis: observational study
Volkova M.I., Feoktistov P.I., Begaliev A.K., Shin A.R., Matveev V.B., Prikhodchenko A.O.
Comparison of afatinib and osimertinib effect on overall survival in first-line drug treatment of EGFR-positive metastatic non-small cell lung cancer: network meta-analysis
Goryaynov S.V.
Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo
Novikov D.V., Polotskiy B.E., Bogush T.A., Davidov M.M., Ahmedov B.B., Rotobelskaya L.E.
New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
Semiglazova T.Y., Klyuge V.A., Semiglazov V.V., Teletaeva G.M., Krivorotko P.V., Dashyan G.A., Paltuev R.M., Tkachenko E.V., Donskikh R.V., Semiglazov V.F.
Comparison of the efficacy of first-line therapy with different generations of EGFR tyrosine kinase inhibitors in patients with advanced EGFR-associated non-small cell lung cancer: a network meta-analysis of overall survival data
Bogdanov A.A., Moiseenko F.V., Egorenkov V.V., Bogdanov A.A., Volkov N.M., Fedyanin M.Y.
Diagnosis and treatment of metastatic melanoma of unknown primary
Krylovetskaya M.A., Komarov I.G., Karseladze D.A.
Insulin-like growth factors in patients with ovarian tumors (results of own research)
Knyazev R.I., Kuznetsov V.V., Bokin I.I., Barinov V.V., Kushlinskiy N.E., Poddubnaya I.V.
Do cancer vaccines help people with advanced non-small cell lung cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Editorial B.
Clinical significance of the pathological type of tumor in common forms of ovarian cancer: A retrospective study
Zhurman V.N.
Treatment of advanced small cell lung cancer. Clinical case and literature review
Menshikov K.V., Sultanbaev A.V., Musin S.I., Menshikova I.A., Nasretdinov A.F., Sultanbaeva N.I.
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
Kolyadina I.V., Poddubnaya I.V.
Is maintenance therapy following previous treatment better than observation or placebo for treating chronic lymphocytic leukaemia in adults? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Editorial B.
Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: sistematic review
Lyadov V.K., Dikova T.S., Zatsepina A.Y., Ivashchenko D.V.
Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer
Samaneva N.I., Vladimirova L.I., Kolyadina I.V., Frantsiyants E.M., Storozhakova A.E., Bandovkina V.A., Kalabanova E.A., Kabanov S.N., Svetitskaya I.V., Tishina A.V., Ezhova M.O.
Clinical significance of the achievement of MRD-negativity in patients with chronic lymphocytic leukemia
Mirolyubova Y.V., Stadnik E.A.
Prognostic value of p53 expression in patients with stage I breast cancer
Kolyadina I.V., Poddubnaya I.V., Van de Velde C.J., Kuppen P.J., Liefers G.J., Dekker-Ensink N.G., Bastiaannet E., Van As-Sajet A., Prinse B., Engels C., Van Vlierberghe R., Komov D.V., Karseladze A.I., Ermilova V.D., Vishnevskaya Y.V., Frank G.A., Banov S.M.
Current treatment aspects of hormone-dependent ERBB2-negative metastatic breast cancer: overall survival outcomes
Snegovoy A.V., Kononenko I.B.
Don’t let it disappear: new opportunities to prolong the life of HR+ HER2- advanced breast cancer patients. Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 28th, 2021
Board E.
Head and neck cutaneous melanoma: an influence of surgical resection margin on long-term results
Pak M.B., Mudunov A.M., Demidov L.V., Azizyan R.I., Brzhezovskiy V.Z., Stelmah D.K., Alymov Y.V., Ignatova A.V.
1 - 37 of 37 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"